COVID-19 in kidney transplant recipient
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026000
- Lead Sponsor
- Seth GS Medical College and KEM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Kidney transplant recipients admitted to KEMH with diagnosis of COVID-19 by
investigation (Positive swab test for COVID-19)
2. Age >18yrs
3. Both genders are to be included
Exclusion Criteria
1. Patients with incomplete medical records
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome of kidney transplant recipients with Covid-19 infectionTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method 1.To find clinical, laboratory imaging features and course of disease <br/ ><br>2. To study the response to therapy <br/ ><br>3. To find predictors and severity of disease in transplant recipients <br/ ><br>Timepoint: 3 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SARS-CoV-2 pathogenesis in kidney transplant recipients?
How does the efficacy of standard-of-care antivirals compare in immunosuppressed renal transplant patients with COVID-19?
Which biomarkers correlate with disease severity and outcomes in CTRI/2020/06/026000 transplant cohort?
What are the management strategies for cytokine storm in kidney transplant recipients with B972-related pneumonia?
How do immunosuppressive regimens impact SARS-CoV-2 infection outcomes in renal allograft recipients?